Study ID: COG ACNS0331
Description:
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
Location:
Sioux Falls Region
Principal Investigator:
Kayelyn Wagner MD
Disease:
CNS (Brain Tumors), LTE (Late Effects), CCL
Stage:
Phase III
Status:
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.
Back to Clinical Trials list